ZUOWEI Unveils Humanoid Care Robots to Address Global Aging Challenges
GUILIN, China, June 25, 2026 /PRNewswire/ -- On June 25, ZUOWEI Technology hosted its "Intelligent Care Beyond Boundaries" global launch in Guilin, officially unveiling two humanoid care robots — Tianshu and Tianji. The launch marks an important step from proof-of-concept to real-world deployment, highlighting the growing role of embodied AI in elderly care. Addressing a Global Caregiving Challenge...
Global Times: Through blood donation, medical practice, and policy consultation, I experience CPC-led social welfare development in Shanghai for years: Nepali Magnolia Gold Award recipient
SHANGHAI, June 25, 2026 /PRNewswire/ -- Sunlight streams through a glass window into a consultation room at a private hospital in Shanghai. On a table by the window sit an array of trophies and certificates: the "Magnolia Gold Award" of Shanghai, the national "Most Beautiful Volunteer," and more. These honors belong to the room's owner, Ashish Maskay, an...
Malaysian Patient Underwent Advanced Heart Procedure at SinoUnited Health
SHANGHAI, June 25, 2026 /PRNewswire/ -- A Malaysian patient has successfully undergone pulse field ablation (PFA) for persistent atrial fibrillation (AF) in Shanghai. The procedure, performed by internationally renowned cardiac electrophysiologist Dr. Feifan Ouyang, has successfully restored the patient's normal heart rhythm, providing effective treatment for longstanding condition. The case highlights Shanghai's growing role as a destination for...
C-Ray Therapeutics Receives Radiopharmaceutical Manufacturing Authorization under China’s MAH Framework
CHENGDU, China, June 25, 2026 /PRNewswire/ -- On June 23, 2026, C-Ray Therapeutics (Chengdu) Co., Ltd. ("C-Ray Therapeutics") completed on-site inspections conducted by a panel of experts from the Sichuan Provincial Center for Drug Evaluation and the National Defense Science and Industry Administration. The company has officially obtained the Radiopharmaceutical Production License. The certification was granted under China's updated...
Dimora Medical has joined the NPIAP Corporate Advisory Council as an Honorary Member
NEW YORK, June 25, 2026 /PRNewswire/ -- Dimora Medical, a continuous innovator in high-end medical care supplies, has officially joined the National Pressure Injury Advisory Panel (NPIAP) as a corporate member, marking a new step in its engagement with the global clinical community focused on pressure injury prevention and care. Dimora & NPIAP Strengthening Responsibility...
ATLATL and Samsung Bioepis Launch ‘Samsung Bioepis Innovation Prize C-Lab Outside’ to Accelerate Early-Stage Biotech Innovation Across Asia-Pacific
Applications Open June 25 for Early-Stage Biotech Companies Developing Next-Generation Therapeutics and Platform Technologies SHANGHAI, June 25, 2026 /PRNewswire/ -- ATLATL Innovation Center ("ATLATL"), a global innovation platform for life science research and development, and Samsung Bioepis Co., Ltd., today announced the launch of the Samsung Bioepis Innovation Prize C-Lab Outside (Innovation Prize), an open innovation initiative designed...
Abu Dhabi Announces Partnership with MSD to Advance Operational Excellence and Expand Access across the Region
ABU DHABI, UAE, June 25, 2026 /PRNewswire/ -- As healthcare systems worldwide seek more resilient and efficient pathways to deliver innovative medicines, the Department of Health – Abu Dhabi (DoH) has announced a collaboration with global pharmaceutical leader MSD (Merck & Co., Inc., Rahway, New Jersey, USA) to explore the feasibility...
REPROCELL Submits Application for Manufacturing and Marketing Approval in Japan for Stem Cell Therapy Stemchymal® for Spinocerebellar Ataxia (SCA3 and SCA6)
YOKOHAMA, Japan, June 24, 2026 /PRNewswire/ -- REPROCELL Inc. today announced the submission of an application for manufacturing and marketing approval in Japan for the regenerative medicine product Stemchymal®, for which the company holds exclusive commercialization rights in Japan. The application seeks approval for the use of Stemchymal® to suppress the...
HKeyBio Debuts HKEY-ExE™ 1.0 to Address Preclinical Bottlenecks in EoE and EgE Drug Development
The EoE-centered framework supports disease modeling, multidimensional efficacy endpoints, type 2 biomarker analysis, and cross-indication translational research BOSTON and SUZHOU, China, June 24, 2026 /PRNewswire/ -- HKeyBio, a preclinical contract research organization focused on autoimmune and allergic diseases, today announced the launch of HKEY-ExE™ 1.0, an EoE&EgE Evaluation Framework for eosinophilic esophagitis (EoE), eosinophilic gastroenteritis (EgE, also referred...
NYSE Content Update: Abridge Partners with Eli Lilly, Nvidia to Improve Healthcare
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, June 24, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. jwplayer.key="3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=" ...
